[Studies with a tritium-labelled N-Lost derivative (cyclophosphamide) in the treatment of carcinoma].
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Nazir P. Kherani + 3 • Aug 27, 2017
Preparation of Tritium Labeled Compounds and Their Scintillation Proximity Assays
Michael P. O'Malley + 2 • Oct 20, 2017
Addition of Rituximab to Fludarabine and Cyclophosphamide in Patients with CLL: A Randomized, Open-Label, Phase III Trial
Oct 17, 2017